Indiana Biosciences Research Institute, Inc.
Indianapolis, IN
- UEI
- K8YCDCTLGEK7
- CAGE
- 7GLS4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 1210 Waterway Blvd #2000, Indianapolis, IN 46202, USA
- Website
- indianabiosciences.org
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Regulatory t cells targeting an islet antigen for treating type 1 diabetes | Defense Health Agency | $340,000 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Indiana University | R01DK149554 | $143,163 | |
| Trustees Of Indiana University | R01AG098161 | $66,071 | |
| Trustees Of Indiana University | P30DK097512 | $31,022 | |
| Trustees Of Indiana University | U54AG090792 | $1,006,808 | |
| Trustees Of Indiana University | U54AG065181 | $2,939,585 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Uhp-Vumc | Amsterdam, NH | 622110 General Medical and Surgical Hospitals |
| Ospedale San Raffaele S.R.L. | Lombardia | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| The Sheba Fund For Health Services And Research (R.a.) | Rehovot, Center District | 622110 General Medical and Surgical Hospitals |
| Dzne E.V. | Bonn, NRW | — |
| Department Of Molecular Immunology | Huntington Beach, CA | — |
About the company
Indiana Biosciences Research Institute, Inc. is a non-profit research institute advancing academic and industry collaboration to improve patient health through translational research. The institute conducts biomedical research focused on developing immunotherapies and other treatments for diseases like type 1 diabetes and Alzheimer's.
Through prime and sub federal grants, Indiana Biosciences Research Institute supports research on immunotherapies targeting islet antigens to treat type 1 diabetes, funded by a $340,000 project grant from the Department of the Army Medical Command's Military Medical Research and Development program. As a sub-awardee, the institute also contributes to Indiana University-led projects on therapeutic combinations for neurofibromatosis type 2 schwannomas, Alzheimer’s disease drug discovery, and diabetes research, supported by the National Institutes of Health. Work performed entails conducting laboratory research and developing novel therapies over multi-year periods.
Quick answers
Is Indiana Biosciences Research Institute, Inc. registered in SAM.gov?
Yes. Indiana Biosciences Research Institute, Inc.'s SAM.gov registration is active through May 11, 2027.
What is Indiana Biosciences Research Institute, Inc.'s most recent federal award?
Indiana Biosciences Research Institute, Inc.'s most recent federal grant award is Regulatory t cells targeting an islet antigen for treating type 1 diabetes (W81XWH2210087), from Defense Health Agency, on February 15, 2022.
On GovTribe
See Indiana Biosciences Research Institute, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors